PCT Network

The PCT Network is a global oncology clinical trial site network that facilitates the rapid execution of cancer research by connecting pharmaceutical sponsors with high-performing investigative sites. Acquired by WCG (WIRB-Copernicus Group) in 2018, the network provides a centralized infrastructure for site identification, feasibility assessment, and patient recruitment. It focuses on reducing the administrative and operational burdens of trial startup, allowing for faster patient enrollment and more efficient drug development. The organization serves a wide range of clients, from emerging biotechnology firms to large pharmaceutical companies, primarily within the oncology and hematology therapeutic areas. By leveraging a curated network of experienced investigators, the PCT Network helps optimize the delivery of innovative therapies to patients.